ARCHIVES

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

January 31, 1992

“Proof Of Concept” Shown In Early Trial Of PKC-412

December 27, 2002

Hey Doc, Wanna Score Some Leucovorin? Drugs Available at 80 Times the Price

October 14, 2011

Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention

January 21, 2011

AACR Membership Up 14 Percent Per Year Since ‘88

June 8, 1990

Support Contracts For Management Info, ODQ Updating Ok’d

October 12, 1990